作者:
Escobar,P.A. [1]
;
Kemper,R.A. [2]
;
Tarca,J. [3]
;
Nicolette,J. [4]
;
Kenyon,M. [5]
;
Glowienke,S. [6]
;
Sawant,S.G. [7]
;
Christensen,J. [8]
;
Johnson,T.E. [9]
;
McKnight,C. [10]
;
Ward,G. [11]
;
Galloway,S.M. [12]
;
Custer,L. [13]
;
Gocke,E. ;
O'Donovan,M.R. ;
Braun,K. ;
Snyder,R.D. ;
Mahadevan,B.
作者单位:
Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877-0368, United States
[1]
Merck Research Laboratories, West Point PA 19486, United States, Abbott Nutrition, Medical Safety
[2]
Merck Research Laboratories, West Point PA 19486, United States, RDS consulting services
[3]
Amgen Inc., Thousand Oaks, CA 91320-1799, United States
[4]
AstraZeneca R and D, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
[5]
Merck Research Laboratories, West Point PA 19486, United States
[6]
Hoffman-La Roche Ltd, Basle, Switzerland
[7]
Novartis Pharma AG, Werk Klybeck Klybeckstrasse 141, Basel, CH-4057, Switzerland
[8]
Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt, Germany
[9]
Pfizer Global Research and Development, Groton, CT, United States
[10]
Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877-0368, United States, Hoffman-La
[11]
AbbVie, Abbott Park, IL 60064-3500, United States
[12]
Bristol Myers-Squib, New Brunswick, NJ 08903, United States
[13]
发布时间
2014-07-12